Research

Hormonal

Treatment with 0.6 mg/day of the long-acting GLP-1 derivative liraglutide for 8 weeks significantly improves glycemic control (reducing fasting glucose and HbA1c) in obese patients with type 2 diabetes without causing weight gain.

If you have type 2 diabetes and are obese, taking 0.6 mg of liraglutide once daily for at least 8 weeks will significantly lower your fasting blood sugar and HbA1c. However, do not expect to lose weight or change your energy expenditure in this timeframe; your weight will likely stay the same. This treatment is effective for blood sugar control without the weight gain often seen with other diabetes drugs.

GoodSupportsHIGH confidence
Eight weeks of 0.6-mg liraglutide treatment significantly improved glycemic control without increasing weight in subjects with type 2 diabetes compared with those on placebo.
Helle Harder et al. · Diabetes Care · 2004

Why this rating

Randomized, double-blind, placebo-controlled trial, though limited by a short duration (8 weeks) and small sample size (n=33).

Source

The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes

Helle Harder et al. · Diabetes Care · 2004

DOI 10.2337/diacare.27.8.1915

rct · n=33Cited 225×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →